메뉴 건너뛰기




Volumn 36, Issue 6, 2012, Pages 551-559

A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN;

EID: 84865505502     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05226.x     Document Type: Article
Times cited : (11)

References (34)
  • 1
    • 7044229778 scopus 로고    scopus 로고
    • Primary liver cancer: Worldwide incidence and trends
    • DOI 10.1053/j.gastro.2004.09.011, PII S0016508504015902
    • Bosch FX, Ribes J, Diaz M, Cleries R,. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-16. (Pubitemid 39423365)
    • (2004) Gastroenterology , vol.127 , Issue.SUPPL.
    • Bosch, F.X.1    Ribes, J.2    Diaz, M.3    Cleries, R.4
  • 2
    • 0023224738 scopus 로고
    • Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival
    • DOI 10.1002/1097-0142(19870 615)59:12<2108::AID-CNCR282 0591225>3.0.CO;2-3
    • Attali P, Prod'Homme S, Pelletier G, et al,. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer 1987; 59: 2108-11. (Pubitemid 17077799)
    • (1987) Cancer , vol.59 , Issue.12 , pp. 2108-2111
    • Attali, P.1    Prod'Homme, S.2    Pelletier, G.3
  • 3
    • 62749123476 scopus 로고    scopus 로고
    • Prognostic indicators in hepatocellular carcinoma: A systematic review of 72 studies
    • Tandon P, Garcia-Tsao G,. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009; 29: 502-10.
    • (2009) Liver Int , vol.29 , pp. 502-510
    • Tandon, P.1    Garcia-Tsao, G.2
  • 4
    • 16244369103 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
    • DOI 10.1002/hep.20636
    • Marrero JA, Fontana RJ, Barrat A, et al,. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16. (Pubitemid 40462931)
    • (2005) Hepatology , vol.41 , Issue.4 , pp. 707-716
    • Marrero, J.A.1    Fontana, R.J.2    Barrat, A.3    Askari, F.4    Conjeevaram, H.S.5    Su, G.L.6    Lok, A.S.7
  • 5
    • 77954016931 scopus 로고    scopus 로고
    • Selecting an optimal staging system for Hepatocellular carcinoma: Comparison of 5 currently used prognostic models
    • Hsu CY, Huang YH, Su CW, et al,. Selecting an optimal staging system for Hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer 2010; 116: 3006-14.
    • (2010) Cancer , vol.116 , pp. 3006-3014
    • Hsu, C.Y.1    Huang, Y.H.2    Su, C.W.3
  • 7
    • 80053267175 scopus 로고    scopus 로고
    • Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement
    • Prasad KR, Young RS, Burra P, et al,. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 2011; 17: S81-9.
    • (2011) Liver Transpl , vol.17
    • Prasad, K.R.1    Young, R.S.2    Burra, P.3
  • 8
    • 40549119470 scopus 로고    scopus 로고
    • Liver transplantation for hepatocellular carcinoma
    • Mazzaferro V, Chun YS, Poon RT, et al,. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008; 15: 1001-7.
    • (2008) Ann Surg Oncol , vol.15 , pp. 1001-1007
    • Mazzaferro, V.1    Chun, Y.S.2    Poon, R.T.3
  • 10
    • 84859902982 scopus 로고    scopus 로고
    • Systematic review: The role of liver transplantation in the management of hepatocellular carcinoma
    • Maggs JR, Suddle AR, Aluvihare V, Heneghan MA,. Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 1113-34.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 1113-1134
    • Maggs, J.R.1    Suddle, A.R.2    Aluvihare, V.3    Heneghan, M.A.4
  • 12
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • DOI 10.1002/hep.20933
    • Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. (Pubitemid 43112690)
    • (2005) Hepatology , vol.42 , Issue.5 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 13
    • 0036829556 scopus 로고    scopus 로고
    • Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
    • DOI 10.1053/jhep.2002.36780
    • Hassan MM, Hwang LY, Hatten CJ, et al,. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-13. (Pubitemid 35253437)
    • (2002) Hepatology , vol.36 , Issue.5 , pp. 1206-1213
    • Hassan, M.M.1    Hwang, L.-Y.2    Hatten, C.J.3    Swaim, M.4    Li, D.5    Abbruzzese, J.L.6    Beasley, P.7    Patt, Y.Z.8
  • 14
    • 77955850168 scopus 로고    scopus 로고
    • EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
    • Gines P, Angeli P, Lenz K, et al,. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
    • (2010) J Hepatol , vol.53 , pp. 397-417
    • Gines, P.1    Angeli, P.2    Lenz, K.3
  • 16
    • 77953120359 scopus 로고    scopus 로고
    • A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring System
    • Hsu CY, Huang YH, Hsia CY, et al,. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 2010; 53: 108-17.
    • (2010) J Hepatol , vol.53 , pp. 108-117
    • Hsu, C.Y.1    Huang, Y.H.2    Hsia, C.Y.3
  • 17
    • 33745320148 scopus 로고    scopus 로고
    • The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy
    • Huo TI, Lin HC, Huang YH, et al,. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 2006; 107: 141-8.
    • (2006) Cancer , vol.107 , pp. 141-148
    • Huo, T.I.1    Lin, H.C.2    Huang, Y.H.3
  • 18
    • 33646541682 scopus 로고    scopus 로고
    • Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy
    • Huo TI, Huang YH, Lin HC, et al,. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 2006; 101: 975-82.
    • (2006) Am J Gastroenterol , vol.101 , pp. 975-982
    • Huo, T.I.1    Huang, Y.H.2    Lin, H.C.3
  • 19
    • 84858658381 scopus 로고    scopus 로고
    • EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma
    • The European Association for the Study of the Liver; The European Organisation for Research and Treatment of Cancer.
    • The European Association for the Study of the Liver; The European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43.
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 20
    • 17244381293 scopus 로고    scopus 로고
    • Percutaneous ablation therapy for hepatocellular carcinoma: Current practice and future perspectives
    • Huo TI, Huang YH, Wu JC,. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc 2005; 68: 155-9.
    • (2005) J Chin Med Assoc , vol.68 , pp. 155-159
    • Huo, T.I.1    Huang, Y.H.2    Wu, J.C.3
  • 22
    • 84875705928 scopus 로고    scopus 로고
    • Systematic review: The prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma
    • Hakeem AR, Young RS, Marangoni G, Lodge JPA, Prasad KR,. Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35: 987-99.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 987-999
    • Hakeem, A.R.1    Young, R.S.2    Marangoni, G.3    Lodge, J.P.A.4    Prasad, K.R.5
  • 23
    • 79959372785 scopus 로고    scopus 로고
    • Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
    • Cabibbo G, Genco C, Di Marco V, et al,. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther 2011; 34: 196-204.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 196-204
    • Cabibbo, G.1    Genco, C.2    Di Marco, V.3
  • 24
    • 0036189111 scopus 로고    scopus 로고
    • Prognostic prediction and treatment strategy in hepatocellular carcinoma
    • DOI 10.1053/jhep.2002.32089
    • Bruix J, Llovet JM,. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24. (Pubitemid 34183954)
    • (2002) Hepatology , vol.35 , Issue.3 , pp. 519-524
    • Bruix, J.1    Llovet, J.M.2
  • 25
    • 80051545416 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
    • D'Avola D, Inarrairaegui M, Pardo F, et al,. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. Ann Surg Oncol 2011; 18: 1964-71.
    • (2011) Ann Surg Oncol , vol.18 , pp. 1964-1971
    • D'Avola, D.1    Inarrairaegui, M.2    Pardo, F.3
  • 26
    • 74049149294 scopus 로고    scopus 로고
    • Review article: The management of hepatocellular carcinoma
    • Cabrera R, Nelson DR,. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 31: 461-76.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 461-476
    • Cabrera, R.1    Nelson, D.R.2
  • 27
    • 80052342926 scopus 로고    scopus 로고
    • Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: A systematic review
    • Cho YK, Rhim H, Noh S,. Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol 2011; 26: 1354-60.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1354-1360
    • Cho, Y.K.1    Rhim, H.2    Noh, S.3
  • 28
    • 84855955803 scopus 로고    scopus 로고
    • Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
    • Wang JH, Wang CC, Hung CH, Chen CL, Lu SN,. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012; 56: 412-8.
    • (2012) J Hepatol , vol.56 , pp. 412-418
    • Wang, J.H.1    Wang, C.C.2    Hung, C.H.3    Chen, C.L.4    Lu, S.N.5
  • 29
    • 84455173830 scopus 로고    scopus 로고
    • Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
    • Nishikawa H, Inuzuka T, Takeda H, et al,. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011; 11: 143.
    • (2011) BMC Gastroenterol , vol.11 , pp. 143
    • Nishikawa, H.1    Inuzuka, T.2    Takeda, H.3
  • 30
    • 79955062942 scopus 로고    scopus 로고
    • Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis
    • Hsu CY, Huang YH, Chiou YY, et al,. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Liver Transpl 2011; 17: 556-66.
    • (2011) Liver Transpl , vol.17 , pp. 556-566
    • Hsu, C.Y.1    Huang, Y.H.2    Chiou, Y.Y.3
  • 31
    • 0033037745 scopus 로고    scopus 로고
    • Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: An analysis of survival in 419 patients
    • Huang YH, Wu JC, Chau GY, et al,. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999; 11: 315-21.
    • (1999) Eur J Gastroenterol Hepatol , vol.11 , pp. 315-321
    • Huang, Y.H.1    Wu, J.C.2    Chau, G.Y.3
  • 32
    • 77955671299 scopus 로고    scopus 로고
    • The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma
    • Dhanasekaran R, Khanna V, Kooby DA, et al,. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21: 1197-204.
    • (2010) J Vasc Interv Radiol , vol.21 , pp. 1197-1204
    • Dhanasekaran, R.1    Khanna, V.2    Kooby, D.A.3
  • 33
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
    • DOI 10.1016/S0140-6736(02)08649-X
    • Llovet JM, Real MI, Montana X, et al,. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9. (Pubitemid 34607087)
    • (2002) Lancet , vol.359 , Issue.9319 , pp. 1734-1739
    • Llovet, J.M.1    Real, M.I.2    Montana, X.3    Planas, R.4    Coll, S.5    Aponte, J.6    Ayuso, C.7    Sala, M.8    Muchart, J.9    Sola, R.10    Rodes, J.11    Bruix, J.12
  • 34
    • 74049091234 scopus 로고    scopus 로고
    • Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma
    • Giannini EG, Bodini G, Corbo M, et al,. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 31: 493-501.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 493-501
    • Giannini, E.G.1    Bodini, G.2    Corbo, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.